首页> 外国专利> CANCER METASTASIS INHIBITOR COMPOSITION COMPRISING EXPRESSION OR ACTIVITY INHIBITOR OF LPA1R AND LPA2R AS ACTIVE COMPONENT

CANCER METASTASIS INHIBITOR COMPOSITION COMPRISING EXPRESSION OR ACTIVITY INHIBITOR OF LPA1R AND LPA2R AS ACTIVE COMPONENT

机译：LPA1R和LPA2R的表达或活性抑制剂作为活性成分的癌症转移抑制剂组成

页面导航

摘要
著录项
相似文献

摘要

The present invention relates to a cancer metastasis inhibitor composition comprising an expression or activity inhibitor of LPA1R or LPA2R as an active component. More specifically, the present invention relates to the cancer metastasis inhibitor composition comprising the expression or activity inhibitor of LPA1R or LPA2R as the active component and a method for inhibiting cancer metastasis comprising a step of administering the composition to a subject.;COPYRIGHT KIPO 2019

机译：本发明涉及一种癌症转移抑制剂组合物，其包含LPA1R或LPA2R的表达或活性抑制剂作为活性成分。更具体地，本发明涉及包含LPA1R或LPA2R的表达或活性抑制剂作为活性成分的癌症转移抑制剂组合物，以及包括步骤将该组合物施用于受试者的抑制癌症转移的方法.COPYRIGHT KIPO 2019

著录项

公开/公告号KR20190068246A

专利类型
公开/公告日2019-06-18

原文格式PDF
申请/专利权人 DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY;
展开▼

申请/专利号KR20170168456
发明设计人 OH YOUNG SEOK;PARK JEONGRAK;JANG JIN HYUK;SHIN CHANG HUN;OH SEOJIN;JEONG MIN SEOK;HWANG A YOU;
展开▼

申请日2017-12-08
分类号A61K48;A61K39;A61K39/395;
国家 KR
入库时间 2022-08-21 11:50:37

相似文献

专利
外文文献
中文文献